CCND1 and exocrine pancreatic carcinoma: GY1-22 inhibits binding between DNAJA1 and p53R175H in cells, which depletes p53R175H and cyclin D1 with increased p21 levels for unclear reasons and inhibits in vivo tumor growth of p53R172H-expressing murine pancreatic carcinoma cells [33].